Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000411945 | SCV000487259 | pathogenic | Autosomal recessive DOPA responsive dystonia | 2016-11-02 | criteria provided, single submitter | clinical testing | |
Invitae | RCV000411945 | SCV001409201 | pathogenic | Autosomal recessive DOPA responsive dystonia | 2023-12-26 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gln232*) in the TH gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TH are known to be pathogenic (PMID: 22264700, 24753243). This variant is present in population databases (no rsID available, gnomAD 0.006%). This premature translational stop signal has been observed in individual(s) with tyrosine hydroxylase deficiency (PMID: 20823027, 22264700). ClinVar contains an entry for this variant (Variation ID: 371630). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV000411945 | SCV005054286 | pathogenic | Autosomal recessive DOPA responsive dystonia | 2024-01-08 | criteria provided, single submitter | clinical testing | |
Center for Molecular Medicine, |
RCV000411945 | SCV002073937 | pathogenic | Autosomal recessive DOPA responsive dystonia | 2022-02-08 | no assertion criteria provided | clinical testing | |
Natera, |
RCV000411945 | SCV002085399 | pathogenic | Autosomal recessive DOPA responsive dystonia | 2020-04-04 | no assertion criteria provided | clinical testing |